Advertisement
Screener

REPLIGEN CORP (RGEN) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

3.0 / 5 stars · 72/120 Roast Me

REPLIGEN CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

REPLIGEN CORP (RGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 0 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-07-29

  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 10.00K shares, a 400.00% increase year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 18.28K shares, a 46.28% decline from fiscal 2024.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 34.03K shares, a 211.35% increase from fiscal 2023.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 10.93K shares, a 31.69% decline from fiscal 2022.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 16.00K shares, a 33.33% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
0.00 shares
10-Q · filed 2026-07-29
10.00K shares
derived: sum of 3 quarters · filed 2026-07-29
10.00K shares
derived: sum of 4 quarters · filed 2026-07-29
2026-03-310.00 shares
10-Q · filed 2026-05-06
10.00K shares
derived: sum of 2 quarters · filed 2026-05-06
10.00K shares
derived: sum of 3 quarters · filed 2026-05-06
17.08K shares
derived: sum of 4 quarters · filed 2026-05-06
2025-12-3110.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
10.00K shares
derived: sum of 2 quarters · filed 2026-02-26
17.08K shares
derived: sum of 3 quarters · filed 2026-02-26
18.28K shares
10-K · filed 2026-02-26
2025-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
7.08K shares
derived: sum of 2 quarters · filed 2025-11-04
8.28K shares
10-Q · filed 2025-11-04
10.28K shares
derived: sum of 4 quarters · filed 2025-11-04
2025-06-307.08K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
8.28K shares
10-Q · filed 2025-08-07
10.28K shares
derived: sum of 3 quarters · filed 2025-08-07
20.28K shares
derived: sum of 4 quarters · filed 2025-08-07
2025-03-311.20K shares
10-Q · filed 2025-04-29
3.20K shares
derived: sum of 2 quarters · filed 2025-04-29
13.20K shares
derived: sum of 3 quarters · filed 2025-04-29
24.25K shares
derived: sum of 4 quarters · filed 2025-04-29
2024-12-312.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
12.00K shares
derived: sum of 2 quarters · filed 2025-03-14
23.06K shares
derived: sum of 3 quarters · filed 2025-03-14
34.03K shares
10-K · filed 2025-03-14
2024-09-3010.00K shares
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-18
21.06K shares
derived: sum of 2 quarters · filed 2024-11-18
32.03K shares
10-Q · filed 2024-11-18
40.96K shares
derived: sum of 4 quarters · filed 2024-11-18
2024-06-3011.06K shares
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
22.03K shares
10-Q/A · filed 2024-11-18
30.96K shares
derived: sum of 3 quarters · filed 2024-11-18
30.96K shares
derived: sum of 4 quarters · filed 2024-11-18
2024-03-3110.97K shares
10-Q/A · filed 2024-11-18
19.90K shares
derived: sum of 2 quarters · filed 2024-11-18
19.90K shares
derived: sum of 3 quarters · filed 2024-11-18
19.90K shares
derived: sum of 4 quarters · filed 2024-11-18
2023-12-318.93K shares
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-11-18
8.93K shares
derived: sum of 2 quarters · filed 2024-11-18
8.93K shares
derived: sum of 3 quarters · filed 2024-11-18
10.93K shares
10-K/A · filed 2024-11-18
2023-09-300.00 shares
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
0.00 shares
derived: sum of 2 quarters · filed 2024-11-18
2.00K shares
10-Q/A · filed 2024-11-18
10.00K shares
derived: sum of 4 quarters · filed 2024-11-18
2023-06-300.00 shares
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
2.00K shares
10-Q/A · filed 2024-11-18
10.00K shares
derived: sum of 3 quarters · filed 2024-11-18
10.00K shares
derived: sum of 4 quarters · filed 2024-11-18
2023-03-312.00K shares
10-Q/A · filed 2024-11-18
10.00K shares
derived: sum of 2 quarters · filed 2024-11-18
10.00K shares
derived: sum of 3 quarters · filed 2024-11-18
18.00K shares
derived: sum of 4 quarters · filed 2024-11-18
2022-12-318.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
8.00K shares
derived: sum of 2 quarters · filed 2023-02-22
16.00K shares
derived: sum of 3 quarters · filed 2023-02-22
16.00K shares
10-K · filed 2023-02-22
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
8.00K shares
derived: sum of 2 quarters · filed 2022-11-01
8.00K shares
10-Q · filed 2022-11-01
14.00K shares
derived: sum of 4 quarters · filed 2022-11-01
2022-06-308.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
8.00K shares
10-Q · filed 2022-08-02
14.00K shares
derived: sum of 3 quarters · filed 2022-08-02
14.00K shares
derived: sum of 4 quarters · filed 2022-08-02
2022-03-310.00 shares
10-Q · filed 2022-04-27
6.00K shares
derived: sum of 2 quarters · filed 2022-04-27
6.00K shares
derived: sum of 3 quarters · filed 2022-04-27
6.00K shares
derived: sum of 4 quarters · filed 2022-04-27
2021-12-316.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
6.00K shares
derived: sum of 2 quarters · filed 2022-02-17
6.00K shares
derived: sum of 3 quarters · filed 2022-02-17
12.00K shares
10-K · filed 2022-02-17
2021-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
0.00 shares
derived: sum of 2 quarters · filed 2021-10-28
6.00K shares
10-Q · filed 2021-10-28
2021-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27
6.00K shares
10-Q · filed 2021-07-27
2021-03-316.00K shares
10-Q · filed 2021-05-04
2019-12-318.00K shares
10-K · filed 2020-02-26
2019-03-310.00 shares
10-Q · filed 2019-05-09
0.00 shares
derived: sum of 2 quarters · filed 2019-05-09
0.00 shares
derived: sum of 3 quarters · filed 2019-05-09
0.00 shares
derived: sum of 4 quarters · filed 2019-05-09
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
0.00 shares
derived: sum of 2 quarters · filed 2019-03-01
0.00 shares
derived: sum of 3 quarters · filed 2019-03-01
9.59K shares
10-K · filed 2019-03-01
2018-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
0.00 shares
derived: sum of 2 quarters · filed 2018-11-01
9.59K shares
10-Q · filed 2018-11-01
10.79K shares
derived: sum of 4 quarters · filed 2018-11-01
2018-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
9.59K shares
10-Q · filed 2018-08-02
10.79K shares
derived: sum of 3 quarters · filed 2018-08-02
12.59K shares
derived: sum of 4 quarters · filed 2018-08-02
2018-03-319.59K shares
10-Q · filed 2018-05-08
10.79K shares
derived: sum of 2 quarters · filed 2018-05-08
12.59K shares
derived: sum of 3 quarters · filed 2018-05-08
18.59K shares
derived: sum of 4 quarters · filed 2018-05-08
2017-12-311.20K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
3.00K shares
derived: sum of 2 quarters · filed 2018-02-22
9.00K shares
derived: sum of 3 quarters · filed 2018-02-22
34.16K shares
10-K · filed 2018-02-22
2017-09-301.80K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
7.80K shares
derived: sum of 2 quarters · filed 2017-11-09
32.96K shares
10-Q · filed 2017-11-09
18.82K shares
derived: sum of 4 quarters · filed 2017-11-09
2017-06-306.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
31.16K shares
10-Q · filed 2017-08-03
17.02K shares
derived: sum of 3 quarters · filed 2017-08-03
34.27K shares
derived: sum of 4 quarters · filed 2017-08-03
2017-03-3125.16K shares
10-Q · filed 2017-05-04
11.02K shares
derived: sum of 2 quarters · filed 2017-05-04
28.27K shares
derived: sum of 3 quarters · filed 2017-05-04
54.85K shares
derived: sum of 4 quarters · filed 2017-05-04
2016-12-31-14.14K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
3.11K shares
derived: sum of 2 quarters · filed 2017-02-23
29.69K shares
derived: sum of 3 quarters · filed 2017-02-23
88.59K shares
10-K · filed 2017-02-23
2016-09-3017.25K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
43.83K shares
derived: sum of 2 quarters · filed 2016-11-03
102.73K shares
10-Q · filed 2016-11-03
148.68K shares
derived: sum of 4 quarters · filed 2016-11-03
2016-06-3026.58K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
85.48K shares
10-Q · filed 2016-08-04
131.43K shares
derived: sum of 3 quarters · filed 2016-08-04
147.63K shares
derived: sum of 4 quarters · filed 2016-08-04
2016-03-3158.90K shares
10-Q · filed 2016-05-05
104.85K shares
derived: sum of 2 quarters · filed 2016-05-05
121.05K shares
derived: sum of 3 quarters · filed 2016-05-05
140.65K shares
derived: sum of 4 quarters · filed 2016-05-05
2015-12-3145.95K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
62.15K shares
derived: sum of 2 quarters · filed 2016-02-25
81.75K shares
derived: sum of 3 quarters · filed 2016-02-25
117.35K shares
10-K · filed 2016-02-25
2015-09-3016.20K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
35.80K shares
derived: sum of 2 quarters · filed 2015-11-05
71.40K shares
10-Q · filed 2015-11-05
71.40K shares
derived: sum of 4 quarters · filed 2015-11-05
2015-06-3019.60K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
55.20K shares
10-Q · filed 2015-08-06
55.20K shares
derived: sum of 3 quarters · filed 2015-08-06
96.32K shares
derived: sum of 4 quarters · filed 2015-08-06
2015-03-3135.60K shares
10-Q · filed 2015-05-08
35.60K shares
derived: sum of 2 quarters · filed 2015-05-08
76.72K shares
derived: sum of 3 quarters · filed 2015-05-08
139.03K shares
derived: sum of 4 quarters · filed 2015-05-08
2014-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
41.12K shares
derived: sum of 2 quarters · filed 2015-03-17
103.43K shares
derived: sum of 3 quarters · filed 2015-03-17
105.83K shares
10-K · filed 2015-03-17
2014-09-3041.12K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
103.43K shares
derived: sum of 2 quarters · filed 2014-11-07
105.83K shares
10-Q · filed 2014-11-07
148.83K shares
derived: sum of 4 quarters · filed 2014-11-07
2014-06-3062.31K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
64.71K shares
10-Q · filed 2014-08-11
107.71K shares
derived: sum of 3 quarters · filed 2014-08-11
286.91K shares
derived: sum of 4 quarters · filed 2014-08-11
2014-03-312.40K shares
10-Q · filed 2014-05-09
45.40K shares
derived: sum of 2 quarters · filed 2014-05-09
224.60K shares
derived: sum of 3 quarters · filed 2014-05-09
247.70K shares
derived: sum of 4 quarters · filed 2014-05-09
2013-12-3143.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
222.20K shares
derived: sum of 2 quarters · filed 2014-03-14
245.30K shares
derived: sum of 3 quarters · filed 2014-03-14
343.50K shares
10-K · filed 2014-03-14
2013-09-30179.20K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
202.30K shares
derived: sum of 2 quarters · filed 2013-11-08
300.50K shares
10-Q · filed 2013-11-08
439.30K shares
derived: sum of 4 quarters · filed 2013-11-08
2013-06-3023.10K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
121.30K shares
10-Q · filed 2013-08-07
260.10K shares
derived: sum of 3 quarters · filed 2013-08-07
318.30K shares
derived: sum of 4 quarters · filed 2013-08-07
2013-03-3198.20K shares
10-Q · filed 2013-05-07
237.00K shares
derived: sum of 2 quarters · filed 2013-05-07
295.20K shares
derived: sum of 3 quarters · filed 2013-05-07
2012-12-31138.80K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
197.00K shares
derived: sum of 2 quarters · filed 2013-03-15
267.60K shares
10-K · filed 2013-03-15
2012-09-3058.20K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
128.80K shares
10-Q · filed 2012-11-08
2012-06-3070.60K shares
10-Q · filed 2012-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78